A review found that CD4/CD8 ratio could be used as a prognostic marker for mortality in patients with HIV, though future studies need to be done to confirm these findings. Clinical practices can ...

Prognostic factors for overall survival of patients with head and neck soft tissue sarcoma based on 25 years data from the Netherlands Cancer registry. This is an ASCO Meeting Abstract from the 2016 ...

Prognostic value of epidermal growth factor receptor (EGFR) family members in breast cancer. Clinical impact of epidermal growth factor receptor (EGFR) coexpression in early breast cancer with human ...

The ratio of CD4 to CD8 T cells in the blood-a marker of immune system health and associated with mortality risk in the general population-is an independent predictor of coronary heart disease in ...

T lymphocytes play a pivotal role in resolving hepatitis B virus infection. This study aimed to investigate the dynamics of peripheral blood T lymphocyte subsets during peginterferon alpha (peg-IFN-α) ...

People with advanced HIV initiating bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) were more likely to reach CD4 cell count levels of 200 cells/mcL or ...

CD4/CD8 T-cell ratios in the renal interstitium significantly mediate the association between peripheral blood CD4+/CD8+ T-cell ratios and lupus nephritis therapeutic outcomes. Peripheral and renal ...

Peripheral blood CD4 + /CD8 + ratios at 12 and 24 weeks may serve as predictive markers for HBsAg clearance in IHCs treated with peg-IFN-α.